Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine at birth to stimulate spontaneous breathing in very preterm infants
NL-OMON41183Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of caffeine in apnea of prematurity (AOP) and respiratory distress syndrome (RDS), sponsored by Leiden University Medical Center. Primary endpoint: Average respiratory minute volume at 7-10 minutes after birth. Started Nov 2014; status: active, not recruiting.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NL-OMON41183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41183.